Journal article
Cullin-5, a ubiquitin ligase scaffold protein, is significantly underexpressed in endometrial adenocarcinomas and is a target of miR-182
Oncology reports, Vol.35(4), pp.2461-2465
04/2016
DOI: 10.3892/or.2016.4605
PMCID: PMC4774736
PMID: 26847831
Abstract
Altered expression of cullin-5 (CUL5), a member of the cullin-RING E3 ubiquitin ligase family, has been implicated in a number of types of cancers including breast, cervical and hepatocellular cancers. In the present study, we found that CUL5 expression was significantly decreased in both endometrioid and serous endometrial adenocarcinomas with the more aggressive serous type displaying a higher reduction (-4.3-fold) than the less aggressive endometrioid type (-2.9-fold). Overexpression of CUL5 mRNA and protein in Ishikawa H endometrial cancer cells resulted in decreased cell proliferation and in a reduction in CUL5-RING E3 ligase downstream clients JAK2 and FAS-L. Finally, we demonstrated for the first time that CUL5 is a direct target of miR-182 that we previously showed to be significantly overexpressed in endometrial adenocarcinomas and we provided evidence that increased miR-182 expression is, at least in part, a result of demethylation of its upstream promoter. These data suggest a cascade in which miR-182 expression is epigenetically increased leading to decreased CUL5 expression and increased cellular proliferation. The final step in the cascade may be operating through a decrease in ubiquitination of pro-growth CUL5 ubiquitin ligase clients. This cascade offers a series of potential interventional steps involving epigenetic modification, miRNA and/or gene targeting and ubiquitination.
Details
- Title: Subtitle
- Cullin-5, a ubiquitin ligase scaffold protein, is significantly underexpressed in endometrial adenocarcinomas and is a target of miR-182
- Creators
- Eric J Devor - Department of Obstetrics and Gynecology, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USABrandon M Schickling - Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USAHenry D Reyes - Department of Obstetrics and Gynecology, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USAAkshaya Warrier - Department of Obstetrics and Gynecology, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USABrittany Lindsay - Department of Obstetrics and Gynecology, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USAMichael J Goodheart - Department of Obstetrics and Gynecology, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USADonna A Santillan - Department of Obstetrics and Gynecology, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USAKimberly K Leslie - Department of Obstetrics and Gynecology, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA
- Resource Type
- Journal article
- Publication Details
- Oncology reports, Vol.35(4), pp.2461-2465
- Publisher
- Greece
- DOI
- 10.3892/or.2016.4605
- PMID
- 26847831
- PMCID
- PMC4774736
- ISSN
- 1021-335X
- eISSN
- 1791-2431
- Grant note
- R01 CA099908 / NCI NIH HHS K12 HD000849 / NICHD NIH HHS K12HD000849 / NICHD NIH HHS R01CA99908 / NCI NIH HHS R01 CA184101 / NCI NIH HHS K12 HD063117 / NICHD NIH HHS P30 CA086862 / NCI NIH HHS
- Language
- English
- Date published
- 04/2016
- Academic Unit
- Obstetrics and Gynecology
- Record Identifier
- 9983931746302771
Metrics
27 Record Views